These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32676506)

  • 21. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
    Sahami-Fard MH; Kheirandish S; Sheikhha MH
    Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific alterations of microRNA transcriptome and global network structure in colorectal carcinoma after cetuximab treatment.
    Ragusa M; Majorana A; Statello L; Maugeri M; Salito L; Barbagallo D; Guglielmino MR; Duro LR; Angelica R; Caltabiano R; Biondi A; Di Vita M; Privitera G; Scalia M; Cappellani A; Vasquez E; Lanzafame S; Basile F; Di Pietro C; Purrello M
    Mol Cancer Ther; 2010 Dec; 9(12):3396-409. PubMed ID: 20881268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells.
    Pehserl AM; Ress AL; Stanzer S; Resel M; Karbiener M; Stadelmeyer E; Stiegelbauer V; Gerger A; Mayr C; Scheideler M; Hutterer GC; Bauernhofer T; Kiesslich T; Pichler M
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27916938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression.
    Kandhavelu J; Subramanian K; Khan A; Omar A; Ruff P; Penny C
    Microrna; 2019; 8(1):68-75. PubMed ID: 30073936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
    Miyoshi J; Toden S; Yoshida K; Toiyama Y; Alberts SR; Kusunoki M; Sinicrope FA; Goel A
    Sci Rep; 2017 Mar; 7():43393. PubMed ID: 28262692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A panel of microRNA signature in serum for colorectal cancer diagnosis.
    Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P
    Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol.
    Sun G; Cheng YW; Lai L; Huang TC; Wang J; Wu X; Wang Y; Huang Y; Wang J; Zhang K; Hu S; Yang JR; Yen Y
    Oncotarget; 2016 Jan; 7(4):3857-72. PubMed ID: 26646696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer.
    Schee K; Lorenz S; Worren MM; Günther CC; Holden M; Hovig E; Fodstad O; Meza-Zepeda LA; Flatmark K
    PLoS One; 2013; 8(6):e66165. PubMed ID: 23824282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA-Sequencing Based microRNA Expression Signature of Colorectal Cancer: The Impact of Oncogenic Targets Regulated by
    Hozaka Y; Kita Y; Yasudome R; Tanaka T; Wada M; Idichi T; Tanabe K; Asai S; Moriya S; Toda H; Mori S; Kurahara H; Ohtsuka T; Seki N
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-transcriptome analysis reveals a potential hsa_circ_0001955/hsa_circ_0000977-mediated miRNA-mRNA regulatory sub-network in colorectal cancer.
    Ding B; Yao M; Fan W; Lou W
    Aging (Albany NY); 2020 Mar; 12(6):5259-5279. PubMed ID: 32221048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression Analysis of Previously Verified Fecal and Plasma Dow-regulated MicroRNAs (miR-4478, 1295-3p, 142-3p and 26a-5p), in FFPE Tissue Samples of CRC Patients.
    Ghanbari R; Rezasoltani S; Hashemi J; Mohamadkhani A; Tahmasebifar A; Arefian E; Mobarra N; Asadi J; Nazemalhosseini Mojarad E; Yazdani Y; Knuutila S; Malekzadeh R
    Arch Iran Med; 2017 Feb; 20(2):92-95. PubMed ID: 28193082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy.
    Manceau G; Imbeaud S; Thiébaut R; Liébaert F; Fontaine K; Rousseau F; Génin B; Le Corre D; Didelot A; Vincent M; Bachet JB; Chibaudel B; Bouché O; Landi B; Bibeau F; Leroy K; Penault-Llorca F; Van Laethem JL; Demetter P; Tejpar S; Rossi S; Mosakhani N; Osterlund P; Ristamäki R; Sarhadi V; Knuutila S; Boige V; André T; Laurent-Puig P
    Clin Cancer Res; 2014 Jun; 20(12):3338-47. PubMed ID: 24771647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiRNAs as molecular biomarkers in stage II egyptian colorectal cancer patients.
    Bahnassy AA; Salem SE; El-Sayed M; Khorshid O; Abdellateif MS; Youssef AS; Mohanad M; Hussein M; Zekri AN; Ali NM
    Exp Mol Pathol; 2018 Dec; 105(3):260-271. PubMed ID: 30213464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-derived exosomal miRNA-320d as a biomarker for metastatic colorectal cancer.
    Tang Y; Zhao Y; Song X; Song X; Niu L; Xie L
    J Clin Lab Anal; 2019 Nov; 33(9):e23004. PubMed ID: 31420913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA profiling differentiates colorectal cancer according to KRAS status.
    Mosakhani N; Sarhadi VK; Borze I; Karjalainen-Lindsberg ML; Sundström J; Ristamäki R; Osterlund P; Knuutila S
    Genes Chromosomes Cancer; 2012 Jan; 51(1):1-9. PubMed ID: 21922590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.
    Gungormez C; Gumushan Aktas H; Dilsiz N; Borazan E
    Mol Biol Rep; 2019 Aug; 46(4):4175-4183. PubMed ID: 31123908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer.
    Qin YZ; Xie XC; Liu HZ; Lai H; Qiu H; Ge LY
    Oncol Rep; 2015 Jun; 33(6):2728-36. PubMed ID: 25845814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-6869-5p acts as a tumor suppressor via targeting TLR4/NF-κB signaling pathway in colorectal cancer.
    Yan S; Liu G; Jin C; Wang Z; Duan Q; Xu J; Xu D
    J Cell Physiol; 2018 Sep; 233(9):6660-6668. PubMed ID: 29206292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer.
    Jin G; Liu Y; Zhang J; Bian Z; Yao S; Fei B; Zhou L; Yin Y; Huang Z
    Cancer Chemother Pharmacol; 2019 Aug; 84(2):315-325. PubMed ID: 31089750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
    Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
    J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.